Skip to Main Content

Can Alnylam find success with its latest cardiac treatment after tweaking the trial? And did STAT’s editorial team pull off a covert mission to get an advanced copy of a new book?

We cover all that and more on this week’s episode of “The Readout LOUD.” STAT reporter Jason Mast joins us to discuss Anthony Fauci’s memoir “On Call,” which was published this week. Hosts Allison DeAngelis and Adam Feuerstein also dissect Alnylam’s forthcoming clinical trial data and take stock of how the biotech markets are succeeding and potentially falling flat midway through the year.


For more on Fauci’s memoir “On Call,” go here; for Adam’s primer on Alnylam’s ATTR-CM trial, go here; read about BridgeBio’s plans here; and for more on biotech startup financing, go here.

STAT+ Exclusive Story


This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Already have an account? Log in



Totals $468 per year

$39/month Get Started

Totals $468 per year



for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month



Save 15%

$399/year Get Started

Save 15%

11+ Users


Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users


Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.


STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect

To submit a correction request, please visit our Contact Us page.